DV
Dividend Vision

CRBU — Caribou Biosciences Inc

Caribou Biosciences Inc (CRBU)

Total return is -90.3% over the past 5.1 years, 179.1 points behind SPY at 88.8%. Its deepest 1-year drawdown was 51.1%.

CRBU is an equity stock fund that tracks Caribou Biosciences Inc, a single-company holding established in July 2021. The fund holds the underlying equity of this biosciences company without an active dividend distribution strategy. The fund currently carries no disclosed expense ratio or yield profile, making it more suitable for investors seeking potential capital appreciation in the biotechnology sector rather than current income generation.

CRBU key facts

Asset type
Stock
Asset class
Equity
Inception date
07/23/2021
Last close
$1.58
Market cap
$163,647,952
Average volume
1188579.0
Beta
2.365
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.42